Transactions
New Horizons Clinical Research recapitalized by NaviMed Capital
Dec. 2017
Client: NHCR operates multi-therapeutic clinical research sites with a depth of clinical expertise in pulmonary / respiratory studies
Role: Edgemont Partners acted as exclusive financial advisor to New Horizons Clinical Research in its recapitalization and merger to form Velocity Clinical Research, Inc. sponsored by NaviMed Capital
Location: Cincinnati, OH
Sector: Pharmaceutical Services
Lead Banker: David Blume
![new horizons clinical research logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/66-Top.png)
recapitalized by
![navimed capital logo](https://edgemont1251.wpenginepowered.com/wp-content/uploads/66-Bottom.png)